The FDA today approved Pfizer's Paxlovid, the first pill authorized to treat COVID-19.
Naturally, there are concerns about how fast Paxlovid will get to market as well as its relatively limited window of use. One must take Paxlovid no more than five days after getting symptoms. The challenge is the gap between feeling symptoms and getting a test result.
But what I wonder is if the third of the country which refuses the Pfizer vaccine (or any other vaccine) will be any more receptive to taking a Pfizer pill to treat COVID. This take on Twitter from Daniel Horowitz (who regularly spreads COVID misinformation) leads me to believe that anti-vaxxers will not be receptive to taking a regimen of pills either.
Mind you these are folks who would rather shove Ivermectin up their ass even though Merck the company which makes it doesn't want people using it to treat COVID. The FDA will soon likely approve Merck's new COVID pill Molnupiravir although France just cancelled an order after disappointing trial results.
On the other hand, if an anti-vaxxer suddenly becomes ill with COVID there is always the chance they could reconsider. How many anti-vaxxers who have become infected with COVID have regretted not getting vaccinated or have reconsidered when family members have become seriously ill? Paxlovid and possibly Molnupiravir gives the anti-vaxxers an option to reconsider and a means of staying out of the hospital. The question is how many will learn the hard way and how many won't learn at all.
No comments:
Post a Comment